Journal profile · Biochemistry & Molecular Biology
Nature Medicine
ISSN 1078-8956 · eISSN 1546-170X · Springer Nature · UNITED STATES · Monthly · Founded 1995
Nature Medicine: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 52.24; hybrid open access; APC about USD 12,690; median 165 days to acceptance (69 articles, last 24 months); community-reported acceptance: about 15%; 748 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Nature Medicine is published by Springer Nature and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Science, Research, and Medicine, Immune Cell Function and Interaction and Immunotherapy and Immune Responses, together about 23.5% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine on the basis of its originality, timeliness, interdisciplinary interest and impact on improving human health. Nature Medicine also publishes commissioned content, including News, Reviews and Perspectives, aimed at contextualizing the latest advances in translational and clinical research to reach a wide audience of M.D. and Ph.D. readers. All editorial decisions are made by a team of full-time professional editors.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry & Molecular Biology
Editorial board by country: 1 in mainland China (about 8%); most named United States 5, United Kingdom 2, Germany 2, Mainland China 1, Italy 1 (12 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Science, Research, and MedicineMedicine9.7%
- Immune Cell Function and InteractionImmunology and Microbiology7.5%
- Immunotherapy and Immune ResponsesImmunology and Microbiology6.3%
- Biotechnology and Related FieldsMedicine5.5%
- HIV Research and TreatmentImmunology and Microbiology5.4%
- Biomedical Ethics and RegulationMedicine5.4%
- T-cell and B-cell ImmunologyImmunology and Microbiology5%
- Health and Medical Research ImpactsMedicine4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Biochemistry & Molecular Biology | Zone 1 |
| Minor | Cell Biology | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Biochemistry & Molecular Biology | Zone 1 |
| Minor | Cell Biology | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Biochemistry & Molecular Biology | Zone 1 |
| Minor | Cell Biology | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 52.24LetPub ·
- Impact factor (publisher) 2025
- 52.5Publisher website ·
- 5-year impact factor (publisher) 2025
- 52.5Publisher website ·
- CiteScore 2026-06
- 73.9LetPub ·
- SJR 2026-06
- 17.5LetPub ·
- SNIP 2026-06
- 9.84LetPub ·
- h-index
- 497LetPub ·
- h-index
- 773OpenAlex ·
- i10-index
- 8,798OpenAlex ·
- 2-year mean citedness
- 32.32OpenAlex ·
- Self-citation rate
- 1.1%LetPub ·
- Share of gold OA articles
- 61.4%LetPub ·
Volume
- Articles per year
- 364LetPub ·
- Downloads per year (publisher) 2025
- 25,697,615Publisher website ·
Articles by year OpenAlex count · 16,790 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 629 | 309 | 2,755 |
| 2025 | 748 | 409 | 23,636 |
| 2024 | 714 | 392 | 41,189 |
| 2023 | 643 | 350 | 51,559 |
| 2022 | 572 | 325 | 72,057 |
| 2021 | 508 | 293 | 89,389 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
165 daysMedian, submission to acceptance · P25–P75 127 days – 239 days
- Acceptance to online
- median 39 days (69 articles)
- Submission to online
- median 217 days
- Sample
- 69 articles with submission and acceptance dates (1,473 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 15%LetPub ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 12,690 / EUR 10,690 / GBP 9,190 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websitePeer review, Preprints
- Peer review 3 – Editorial Process, Peer Review, Appeals & Transfers
Once you have submitted your manuscript, it goes through our editorial process. If your manuscript is sent out for peer review, you will receive an email asking you to read and sign our Editorial Policies. To appeal against a decision, or transfer your submission to another journal – Appeals and Transfers. ____________________________________________________________________________________________…
Source ↗Publisher website ·- Preprints
Editorial policies Model summary
Read and understand our policies – Editorial policies
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1995
- ISSN
- 1078-8956
- Electronic ISSN
- 1546-170X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Nature Medicine
What CAS zone is Nature Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Nature Medicine is in Zone 1 of Medicine, and in Zone 1 of the minor category Biochemistry & Molecular Biology / Cell Biology / Medicine, Research & Experimental; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Nature Medicine?
The latest impact factor listed by LetPub is 52.24; CiteScore 73.9, h-index 773.
How long does peer review take at Nature Medicine?
Based on the dates recorded on 69 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 165 days (interquartile range 127–239 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 15%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Nature Medicine based?
Of the 12 board members whose country the journal's board page names, 1 (about 8%) are in mainland China; the countries named most often are United States (5), United Kingdom (2) and Germany (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Nature Medicine?
According to LetPub and DOAJ records, Nature Medicine is indexed in SCIE and Scopus. The journal's website also lists Web of Science; that list has not been checked against each database.
Is Nature Medicine open access, and what is the APC?
Nature Medicine is a hybrid journal. For open-access publication: APC about USD 12,690.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .